Elçin KAL ÇAKMAKLIOĞULLARI, Murat ÇAKMAKLIOĞULLARI

Seroprevalence of HBsAg, Anti-HCV and HIV in patientsundergoing ocular surgery

Aim: In this study, we aimed to detect the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and humanimmunodeficiency virus (HIV) in patients undergoing ocular surgery. Materials and Methods: HBsAg, anti-HCV, and HIVtestresults of patients who were admitted to the Department of Ophthalmologyof the Karabuk University Training and Research Hospital between March 2016 and April 2019 were retrospectively reviewed.HBsAg (Abbott Diagnostics, USA), anti-HCV(Abbott Diagnostics, USA) and HIV Ag/Ab Combo tests (Abbott Diagnostics, USA) wereassessed by chemiluminescence microparticleenzymeimmunoassaymethod byusingAbbottDiagnosticskits andARCHITECT i2000SR (Abbott Diagnostics, USA) immunoassayanalyzer. Patients were divided into four groups according to age: 20–39, 40–59, 60–79,and 80 years old and above. Seropositive patients were evaluated in terms of the surgical method applied. Results: Of 1504 patients included in the study, 768 (51%) were men and 736 (49%) were women, and the mean age was 70 years.HBsAg positivity was 0.79% (12/1504) and anti-HCV positivity was 2.06% (31/1504). HIV Ag/Ab Combo was negative in all patients.There were no HBsAg and anti-HCV-positive patients in the 20–39 years age group, whereasone HBsAg (0.06%) and twoanti-HCV(0.13%) positivity in the 40–59 years age group and11 HBsAg (0.73%) and 23 anti-HCV (1.52%) positivity in the 60–79 years agegroup were detected. Although HBsAg was negative in all patients over 80 years old, anti-HCV was positive in 6(0.39%) patients.Further, eight of 12 HBsAg-positive patients underwent cataracts surgery and four lacrimal canal surgery, and 24 of 31 anti-HCVpositive patients underwent cataracts surgery, five lacrimal canal surgery, and two eyelid surgery. Conclusion: All patients should be tested for HBsAg, anti-HCV, and HIV preoperatively. Seropositive patients should be informedabout viral hepatitis and should be referred to the infectious diseases department. Necessary precautions should be taken to preventcontamination to healthcare professionals and other patients during operation and medical care.

PDF

___

1. World Health Organization. WHO Global Hepatitis Report; 2017. Availablefrom: http://www.who.int/ mediacentre/news/releases/2017/global hepatitis report/en/. [Lastaccessed on 2017 Oct 18].
2. World Health Organization. Global Health Observatory (GHO) Data. Availablefrom: http://www.who.int/gho/ hiv/epidemic_status/cases_all/en/. [Last accessed on 2017 Oct 18].
3. Ozkan H. HBV treatment in Turkey: The value of hepatitis B surface antigen quantification of chronic hepatitis B patients in thelong-termfollow-up-a single-centerstudy. Euroasian J Hepatogastroenterol 2017;7:82-83.
4. Celdir MG, Kara IA, Coşkuner SB, et al. Hepatitis C prevalence in Turkey: Estimation through metaanalysis. Eur J PubHeal 2014;24:168-9.
5. Collins CH, Kennedy DA. Microbiological hazards of occupational needles tick and ‘sharps’ injuries. J ApplBacteriol 1987;62:385-402.
6. Ching-YaoTsai, Chih-LinLin, Shiao-Cheng Lin, et al. Detection of Hepatitis B Virus in the Aqueous Humor of a Hepatitis B Virus Carrier. Opthalmologica 2009;223:93-5.
7. Sahu GK, McNearney T, Evans A, etal. Transient or occult HIV infections may occur more frequently than progressive infections: changing the paradigm about HIV persistence. Arch Virol Suppl 2005;19:131-45.
8. Raimondo G, Pollicino T, Cacciola I, etal. Occulthepatitis B virusinfection. J Hepatol 2007;46:160-70.
9. Tahir MA, Cheema A, Tareen S. Frequency of hepatitis-B and C in patients undergoing cataract surgery in a tertiary care centre. Pak J MedSci2015;31:895-8.
10. Ambastha A, Kusumesh R, Bhasker G. Why should viral markers be mandatory in ocular surgeries: A Hospital based retrospective study. J Clin Diagn Res 2016;10:9-11.
11. Alhassan MB, Unung P, Adejor G. HIV and HBsAg seropositivity amongs patients presenting for ocular surgery at a tertiary eye care hospital in Nigeria. Open Ophthalmol J 2013;7:18-9.
12. Baumert TF, Meredith L, Ni Y, et al. Entry of hepatitis B and C viruses -recen t progress and future impact. Curr Opin Virol 2014;4C:58-65.
13. Coppola N, De Pascalis S, Onorato L, et al. Hepatitis B virus and hepatitis C virus infection in health care workers. World J Hepatol 2016;8:273-81.
14. Shoaei P, Lofti N, Hassannejad R, et al. Seroprevalence of hepatitis C infection among laboratory health care workers in Isfahan, Iran. Int J PrevMed 2012;3:146-9.
15. Kose S, Odemiş I, Celik D, et al. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics. Infez Med 2017;25:339- 43.
16. Inci H, Asgin N, Inci F et al. Seroprevalence of Viral Hepatitis According to Age Groups in Individuals Applying to a University Hospital Family Medicine Polyclinic. Konuralp Med J 2020;12:34-8.
17. Denk A, Balin SO. Koroner Anjiyografi Yapılan Hastalarda HBsAg, Anti-HCV ve Anti-HIV Seropozitifliği. Firat Med J 2016;21:125-8.
18. Inci A, Yildirim D, Seckin KD, et al. Analysis of HbsAg positivity rate before and after vaccination in Turkish and Syrian refugee pregnant women. J Infect Dev Ctries 2017;11:815-8.
19. Asgin N, Satilmıs S. An Evaluation of Hepatitis B Virus and Hepatitis C Virus Frequency and the Antihepatitis B Surface Seropositivity of Syrian Refugees in the Karabük Province. Viral Hepat J 2019;25:84-7.
20. Tumturk A, Yesil B. Hepatitis B, Hepatitis C and HIV seroprevalence among Syrian refugees: A crosssectional study from a tertiary referral center in Turkey. J Surg Med 2019;3:845-7.
21. Asgin N, Satilmis S. Evaluation of hepatitis B virus and Hepatitis C virus frequency in hemodialysis patients. Ann Med Res 2019;26:3007-11.
22. EserKarlidag G, Kuçuksu M, Demir M. HBsAg, Anti-HBs, Anti-HCV and HIV Seroprevalence in Hemodialysis Patients in Elazığ Province. Viral Hepat J 2018;24:53- 6.
23. Nangrejo KM, Qureshi MA, Sahto AA, et al.Prevalence of Hepatitis B and C in the patients Undergoing Cataract Surgery at Eye Camps. Pak J Ophthalmol 2011;27:1.
24. Tozun N, Ozdogan O, CakalogluY, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a field work TURHEP study. Clin Microbiol Infect 2015;21:1020-6.
25. Ahmad I, Khan BS, Rehman UH, et al. Frequency of Hepatitis B and Hepatitis C among cataract patients. Gomal J Med Sci 2006;4:61-4.
26. Naeem SS, Siddiqui EU, Kazi AN, et al. Prevalence of Hepatitis ‘B’ and Hepatitis ‘C’ among preoperative cataract patients in Karachi. BMC Research Notes 2012;5:492.
27. Beltrami EM, Williams IT, Shapiro CN, et al. Risk and management of blood borne infections in healthcare workers. Clin Microbiol Rev 2000;13:385-407.
28. Moloughney BW. Transmission and postexposure management of blood borne virus infections in the health care setting: Where are we now? Canadian Medical Association Journal 2001;165:445-51.
29. Guzelant A, Kurtoglu M, Kaya M, et al. The Seroprevalence Of Hepatitis B, Hepatitis C And Hiv In Blood Donors And Workers In A Dentistry Center And Risk Factors For Infection In Blood Donors. Turkish J Infection 2008;22:189-95.
30. Temel A, Seber E, Gunay M. Detection of hepatitis B surfaceantigen in aqueoushumor. Acta Ophthalmol (Copenh) 1990;68:205-8.
31. Atas M, KaratepeHashas AS, Demircan S, et al. The investigation of HCV RNA in tearfluid and aqueoushumor in patients with anti HCV antibody positive who underwent cataract surgery. Ocul Immunol Inflamm 2016;24:297 301.
32. Kashiwagi K, Gohdo T, Sato S, et al. Detection of HIV RNA in aqueoushumor and subretinal fluid in an HIV carrier with rhegmatogenous retinal detachment. Jpn J Ophthalmol 2000;44:687-9.
33. Koksal I, Cetinkaya K, Aker F. Hepatitis B surface antigen in tears and aqueoushumor. Ophthalmologica1992;204;19-22.
34. Han Y, Wu N, Zhu W,et al. Detection of HIV-1 viruses in tears of patient seven underlong-term HAART. Aids. 2011;25:1925-7.